Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy

被引:123
作者
Kubo, Toru [1 ]
Kitaoka, Hiroaki [1 ]
Yamanaka, Shigeo [2 ]
Hirota, Takayoshi [1 ]
Baba, Yuichi [1 ]
Hayashi, Kayo [1 ]
Iiyama, Tatsuo [3 ]
Kumagai, Naoko [3 ]
Tanioka, Katsutoshi [1 ]
Yamasaki, Naohito [1 ]
Matsumura, Yoshihisa [1 ]
Furuno, Takashi [1 ]
Sugiura, Tetsuro [2 ]
Doi, Yoshinori L. [1 ]
机构
[1] Kochi Med Sch, Dept Med & Geriatr, Kochi, Japan
[2] Kochi Med Sch, Dept Lab Med, Kochi, Japan
[3] Kochi Med Sch, Clin Trial Ctr, Kochi, Japan
基金
日本学术振兴会;
关键词
biomarker; high-sensitivity cardiac troponin T; hypertrophic cardiomyopathy; prognosis; LEFT-VENTRICULAR HYPERTROPHY; MAGNETIC-RESONANCE; CLINICAL-COURSE; DELAYED ENHANCEMENT; ATRIAL-FIBRILLATION; SUDDEN-DEATH; RISK; DYSFUNCTION; ARRHYTHMIAS; SEVERITY;
D O I
10.1016/j.jacc.2013.03.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study investigated the significance of the serum high-sensitivity cardiac troponin T (hs-cTnT) marker for prediction of adverse events in hypertrophic cardiomyopathy (HCM). Background Although serum cardiac troponins as sensitive and specific markers of myocardial injury have become well-established diagnostic and prognostic markers in acute coronary syndrome, the usefulness of hs-cTnT for prediction of cardiovascular events in patients with HCM is unclear. Methods We performed clinical evaluation, including measurements of hs-cTnT in 183 consecutive patients with HCM. Results Of 183 HCM patients, 99 (54%) showed abnormal hs-cTnT values (>0.014 ng/ml). During a mean follow-up of 4.1 +/- 2.0 years, 32 (32%) of the 99 patients in the abnormal hs-cTnT group, but only 6 (7%) of 84 patients with normal hs-cTnT values, experienced cardiovascular events: cardiovascular deaths, unplanned heart failure admissions, sustained ventricular tachycardia, embolic events, and progression to New York Heart Association functional class III or IV status (hazard ratio [HR]: 5.05, p < 0.001). Abnormal hs-cTnT value remained an independent predictor of these cardiovascular events after multivariate analysis (HR: 3.23, p = 0.012). Furthermore, in the abnormal hs-cTnT group, overall risk increased with an increase in hs-cTnT value (HR: 1.89/hs-cTnT 1 SD increase in the logarithmic scale, 95% confidence interval: 1.13 to 3.15; p = 0.015 [SD: 0.59]). Conclusions In patients with HCM, an abnormal serum concentration of hs-cTnT is an independent predictor of adverse outcome, and a higher degree of abnormality in hs-cTnT value is associated with a greater risk of cardiovascular events. (C) 2013 by the American College of Cardiology Foundation
引用
收藏
页码:1252 / 1259
页数:8
相关论文
共 28 条
[1]   Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy on relation to delayed enhancement on cardiovascular magnetic resonance [J].
Adabag, A. Selcuk ;
Maron, Barry J. ;
Appelbaum, Evan ;
Harrigan, Caltlin J. ;
Buros, Jacqueline L. ;
Gibson, C. Michael ;
Lesser, John R. ;
Hanna, Constance A. ;
Udelson, James E. ;
Manning, Warren J. ;
Maron, Martin S. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) :1369-1374
[2]   The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms [J].
Autore, C ;
Bernabò, P ;
Barillà, CS ;
Bruzzi, P ;
Spirito, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) :1076-1080
[3]   HYPERTROPHIC CARDIOMYOPATHY IN TUSCANY - CLINICAL COURSE AND OUTCOME IN AN UNSELECTED REGIONAL POPULATION [J].
CECCHI, F ;
OLIVOTTO, I ;
MONTEREGGI, A ;
SANTORO, G ;
DOLARA, A ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (06) :1529-1536
[4]   Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy [J].
Elliott, PM ;
Blanes, JRG ;
Mahon, NG ;
Poloniecki, JD ;
McKenna, WJ .
LANCET, 2001, 357 (9254) :420-424
[5]   Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure [J].
Horwich, TB ;
Patel, J ;
MacLellan, WR ;
Fonarow, GC .
CIRCULATION, 2003, 108 (07) :833-838
[6]   Prognostic Role of High-Sensitivity Cardiac Troponin T in Patients With Nonischemic Dilated Cardiomyopathy [J].
Kawahara, Chiho ;
Tsutamoto, Takayoshi ;
Nishiyama, Keizo ;
Yamaji, Masayuki ;
Sakai, Hiroshi ;
Fujii, Masanori ;
Yamamoto, Takashi ;
Horie, Minoru .
CIRCULATION JOURNAL, 2011, 75 (03) :656-661
[7]   Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration [J].
Kofflard, MJM ;
Ten Cate, FJ ;
van der Lee, C ;
van Domburg, RT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) :987-993
[8]   Clinical Impact of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy-Results From Kochi RYOMA Study- [J].
Kubo, Toru ;
Kitaoka, Hiroaki ;
Okawa, Makoto ;
Hirota, Takayoshi ;
Hayato, Kayo ;
Yamasaki, Naohito ;
Matsumura, Yoshihisa ;
Yabe, Toshikazu ;
Takata, Jun ;
Doi, Yoshinori L. .
CIRCULATION JOURNAL, 2009, 73 (09) :1599-1605
[9]   Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy [J].
Leonardi, Sergio ;
Raineri, Claudia ;
De Ferrari, Gaetano M. ;
Ghio, Stefano ;
Scelsi, Laura ;
Pasotti, Michele ;
Tagliani, Marilena ;
Valentini, Adele ;
Dore, Roberto ;
Raisaro, Arturo ;
Arbustini, Eloisa .
EUROPEAN HEART JOURNAL, 2009, 30 (16) :2003-2010